Orphanet: Search for an orphan drug
x

Search for an orphan drug

* (*) mandatory field

Other search option(s)

Marketing authorization with orphan designation - Europe

Therapeutic indication

As monotherapy for the treatment of adult patients who have relapsed or refractory acute myeloid leukaemia (AML) with a FLT3 mutation.

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.